Though the growth factors such as VEGF induce strong angiogenesis, incorporating them before scaffold processing could reduce their potency, whereas applying them at end stage could produce non-desired side effects, including cancer outside the scaffold area [36]. This evidence concerns the gene VEGFA and cancer.